Cell cycle analysis performed by flow cytometry after 24 hours of treatment with SNP, TRAIL, and SNP plus TRAIL
Cells and treatment . | Percentage of cells . | ||
---|---|---|---|
G1 . | S . | G2/M . | |
HEL | |||
Control | 41 | 31 | 28 |
SNP | 33 | 39 | 28 |
TRAIL | 36 | 37 | 26 |
TRAIL + SNP | 40 | 40 | 20 |
HL-60 | |||
Control | 66 | 21 | 13 |
SNP | 45 | 36 | 19 |
TRAIL | 50 | 39 | 11 |
TRAIL + SNP | 56 | 32 | 12 |
Jurkat | |||
Control | 63 | 27 | 10 |
SNP | 50 | 32 | 18 |
TRAIL | 54 | 33 | 13 |
TRAIL + SNP | 50 | 41 | 9 |
SupT1 | |||
Control | 73 | 16 | 11 |
SNP | 60 | 23 | 17 |
TRAIL | 54 | 33 | 13 |
TRAIL + SNP | 58 | 33 | 9 |
Normal erythroblast | |||
Control | 38 | 41 | 21 |
SNP | 30 | 50 | 20 |
TRAIL | 37 | 43 | 20 |
TRAIL + SNP | 33 | 48 | 19 |
Normal granulocytic cells | |||
Control | 73 | 21 | 6 |
SNP | 72 | 22 | 6 |
TRAIL | 72 | 23 | 5 |
TRAIL + SNP | 71 | 23 | 6 |
Cells and treatment . | Percentage of cells . | ||
---|---|---|---|
G1 . | S . | G2/M . | |
HEL | |||
Control | 41 | 31 | 28 |
SNP | 33 | 39 | 28 |
TRAIL | 36 | 37 | 26 |
TRAIL + SNP | 40 | 40 | 20 |
HL-60 | |||
Control | 66 | 21 | 13 |
SNP | 45 | 36 | 19 |
TRAIL | 50 | 39 | 11 |
TRAIL + SNP | 56 | 32 | 12 |
Jurkat | |||
Control | 63 | 27 | 10 |
SNP | 50 | 32 | 18 |
TRAIL | 54 | 33 | 13 |
TRAIL + SNP | 50 | 41 | 9 |
SupT1 | |||
Control | 73 | 16 | 11 |
SNP | 60 | 23 | 17 |
TRAIL | 54 | 33 | 13 |
TRAIL + SNP | 58 | 33 | 9 |
Normal erythroblast | |||
Control | 38 | 41 | 21 |
SNP | 30 | 50 | 20 |
TRAIL | 37 | 43 | 20 |
TRAIL + SNP | 33 | 48 | 19 |
Normal granulocytic cells | |||
Control | 73 | 21 | 6 |
SNP | 72 | 22 | 6 |
TRAIL | 72 | 23 | 5 |
TRAIL + SNP | 71 | 23 | 6 |
The percentage of cells with a G1(2n), S, G2/M(4n) DNA content, were calculated after removal of the apoptotic cells. Data represent the means of 3 separate experiments. SDs were comprised within 10% of the means and are omitted for clarity.